OCT 20, 2016 3:55 AM PDT

Race and Gender in Stroke Treatment

When it comes to stroke, time is brain; this is a well-known medical fact. Getting the correct treatment immediately is crucial. So why would gender or race enter into the equation? With more people knowing the signs of stroke (FAST—Face, Arms, Speech and Time) and more medical facilities being equipped to treat stroke patients, it would seem that gender or race would have no impact on outcomes. As it happens, there is an impact, at least if the latest research is correct. A new study published online in the journal Neurology, a publication of the American Academy of Neurology, suggests that women and minorities may be slipping through the cracks in stroke treatment.
While there are different kinds of strokes, the most common by far, at 9 out of 10, are ischemic strokes, where a blood clot is blocking blood flow to the brain. In this kind of stroke the gold standard for treatment is the administration of tissue plasminogen activator (tPA). tPA drug therapy can break up a clot fairly quickly, removing the obstruction to blood flow. However, if patients are not given the drug, it cannot work and the latest research shows that women and minorities are at a disadvantage in this situation, at least statistically.

Study author Steven R. Messé, MD, of the University of Pennsylvania in Philadelphia and a Fellow of the American Academy of Neurology said, “Even though the clot-busting treatment for stroke called tPA improves recovery, some people who are eligible to receive the treatment are not getting it. We wanted to find out what factors were associated with lower likelihood of treatment, which may help us find ways to improve tPA use in the future.”

The study was a meta-analysis, where the team combined through thousands of pages of data. The hospital records of patients who arrived at the emergency department within two hours of the onset of stroke symptoms and were eligible for the drug, with no contraindications, were analyzed during an 8 year period from 2003 to 2011. In total, the team looked at 61,698 ischemic stroke patients.
After taking into account confounding factors including stroke severity, the researchers found that women and minorities were less likely to receive treatment. Of the records examined, 50.6% were from women, but female patients had an 8% higher chance of not receiving life-saving tPA treatment compared to men. African American patients were especially at risk, having 26% higher chance of missing out on tPA therapy compared to white patients. These two groups of patients combined made up over half of the patients included in the study and yet they were at a significantly higher risk of being under-treated.

It did matter where treatment was received. Patients treated at hospitals that were certified as stroke centers were much more likely to receive the gold standard of tPA treatment. Patients who were treated at hospitals that were not certified as stroke centers were half as likely to receive the clot busting drugs. The study was supported in part by Pfizer, Inc., and the Merck-Schering Plough Partnership. The video below talks about the symptoms of stroke and the impact they can have on the body, make sure you know the signs.

Sources: American Academy of Neurology , National Stroke AssociationPerelman School of Medicine UPennJournal Neurology
About the Author
  • I'm a writer living in the Boston area. My interests include cancer research, cardiology and neuroscience. I want to be part of using the Internet and social media to educate professionals and patients in a collaborative environment.
You May Also Like
SEP 03, 2020
Health & Medicine
High BMI and Waist Circumference Increase Dementia Risk
SEP 03, 2020
High BMI and Waist Circumference Increase Dementia Risk
New research from University College London (UCL) provides another link between obesity and dementia risk. The study cit ...
OCT 11, 2020
Cell & Molecular Biology
Newly-Found Molecules May Treat Neurodegeneration
OCT 11, 2020
Newly-Found Molecules May Treat Neurodegeneration
The NMDA receptor is known to play a crucial role in memory, and synaptic plasticity - where neurons change, altering ne ...
OCT 12, 2020
Cannabis Sciences
Can Cannabis Relieve Symptoms of Down Syndrome?
OCT 12, 2020
Can Cannabis Relieve Symptoms of Down Syndrome?
Increasing anecdotal and academic evidence has been emerging in recent years about the plethora of health benefits behin ...
OCT 13, 2020
Neuroscience
Sleep Apnea and Alzheimer's Damage Brain in Same Way
OCT 13, 2020
Sleep Apnea and Alzheimer's Damage Brain in Same Way
Sleep apnea is characterized by breathing that repeatedly stops and starts, loud snoring, restless sleep, and sleepiness ...
NOV 07, 2020
Neuroscience
Device Measures Stress Hormones with Earwax
NOV 07, 2020
Device Measures Stress Hormones with Earwax
Researchers from University College London and King’s College London in the UK have developed a device that can me ...
NOV 13, 2020
Cell & Molecular Biology
Astrocytes are Star Players in the Brain
NOV 13, 2020
Astrocytes are Star Players in the Brain
As neurons fire, they enable us to think and move. They signal to one another where they meet at synapses, and at chemic ...
Loading Comments...